153 related articles for article (PubMed ID: 30002424)
1. Variation in fluoroquinolone pharmacodynamic parameter values among isolates of two bacterial pathogens of bovine respiratory disease.
Wen X; Gehring R; Riviere JE; Lubbers BV; Gaire TN; Wyche B; Fox B; Quichocho V; Volkova VV
Sci Rep; 2018 Jul; 8(1):10553. PubMed ID: 30002424
[TBL] [Abstract][Full Text] [Related]
2. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
Sweeney MT; Papich MG; Watts JL
J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
[TBL] [Abstract][Full Text] [Related]
3. Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease: How Are They Changing in Response to Efforts to Control Them?
Snyder E; Credille B
Vet Clin North Am Food Anim Pract; 2020 Jul; 36(2):253-268. PubMed ID: 32327253
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
[TBL] [Abstract][Full Text] [Related]
5. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
Holschbach CL; Aulik N; Poulsen K; Ollivett TL
J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
[TBL] [Abstract][Full Text] [Related]
7. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
[TBL] [Abstract][Full Text] [Related]
8. Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species.
Wen X; Gehring R; Stallbaumer A; Riviere JE; Volkova VV
Sci Rep; 2016 Dec; 6():37907. PubMed ID: 27905408
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
11. Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica.
Michael GB; Eidam C; Kadlec K; Meyer K; Sweeney MT; Murray RW; Watts JL; Schwarz S
J Antimicrob Chemother; 2012 Jun; 67(6):1555-7. PubMed ID: 22398653
[No Abstract] [Full Text] [Related]
12. Pharmacodynamics of florfenicol for calf pneumonia pathogens.
Illambas J; Potter T; Sidhu P; Rycroft AN; Cheng Z; Lees P
Vet Rec; 2013 Mar; 172(13):340. PubMed ID: 23482237
[TBL] [Abstract][Full Text] [Related]
13. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
[TBL] [Abstract][Full Text] [Related]
14. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
Sweeney MT; Brumbaugh GW; Watts JL
Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance conferred by rRNA mutations in field isolates of Mannheimia haemolytica and Pasteurella multocida.
Olsen AS; Warrass R; Douthwaite S
J Antimicrob Chemother; 2015 Feb; 70(2):420-3. PubMed ID: 25261417
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
Crosby S; Credille B; Giguère S; Berghaus R
J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
Schwarz S; Kehrenberg C; Salmon SA; Watts JL
J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
